Literature DB >> 7966417

Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells.

R Fujii1, M Mutoh, T Sumizawa, Z S Chen, A Yoshimura, S Akiyama.   

Abstract

BACKGROUND: Cisplatin accumulation is decreased in many cisplatin-resistant cells. An active efflux pump for cisplatin exists in cisplatin-resistant human epidermoid carcinoma cells (called KB cells). A previous study has suggested that the adenosine triphosphate (ATP)-dependent glutathione S-conjugate export pump (GS-X pump), which exports the bis-(glutathionato)-platinum (II) (GS-platinum) complex, could contribute to cellular resistance to cisplatin.
PURPOSE: In this study, we examined whether the active efflux pump for cisplatin in the cisplatin-resistant KB cells is the GS-X pump and tested its activity by using an endogenous substrate, [3H]leukotriene C4 ([3H]LTC4).
METHODS: Membrane vesicles were prepared from KB-3-1 (clone from parental KB cells) cells and from cisplatin-resistant KCP-4 (a mutant clone derived from KB-3-1 cells) cells. Using a filtration technique, we measured the uptake and transport of [3H]LTC4, a substrate for the GS-X pump, into membrane vesicles at 37 degrees C.
RESULTS: The uptake of [3H]LTC4 in the membrane vesicles from both the KB-3-1 and KCP-4 cells was ATP-dependent. In contrast, the ATP-dependent transport of [3H]LTC4 was observed only in KCP-4 membrane vesicles but not in KB-3-1 membrane vesicles. The ATP-dependent transport was vanadate sensitive and was inhibited by GS-platinum complex but only marginally by cisplatin and glutathione and not by vincristine or verapamil. The nucleotide triphosphates, guanosine triphosphate, cytidine triphosphate, uridine triphosphate, and deoxythymidine triphosphate could be substituted for ATP but were less efficient. A nonhydrolyzable ATP analogue, adenosine 5'-(beta,gamma-methylene) triphosphate, was not effective.
CONCLUSIONS: The transport of LTC4 in membrane vesicles prepared from KCP-4 cells was facilitated by an ATP-dependent pump that appeared very similar to the GS-X pump. IMPLICATIONS: Our study suggests that the GS-X pump is involved in the decreased accumulation of cisplatin in KCP-4 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966417     DOI: 10.1093/jnci/86.23.1781

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum.

Authors:  K Ikeda; K Miura; S Himeno; N Imura; A Naganuma
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1.

Authors:  R Tommasini; R Evers; E Vogt; C Mornet; G J Zaman; A H Schinkel; P Borst; E Martinoia
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer.

Authors:  Jimmy Belotte; Nicole M Fletcher; Awoniyi O Awonuga; Mitchell Alexis; Husam M Abu-Soud; Mohammed G Saed; Michael P Diamond; Ghassan M Saed
Journal:  Reprod Sci       Date:  2013-09-27       Impact factor: 3.060

4.  Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.

Authors:  G J Zaman; J Lankelma; O van Tellingen; J Beijnen; H Dekker; C Paulusma; R P Oude Elferink; F Baas; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells.

Authors:  G Chen; K J Hutter; W J Zeller
Journal:  Cell Biol Toxicol       Date:  1995-10       Impact factor: 6.691

6.  Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.

Authors:  T Oguri; Y Fujiwara; T Isobe; O Katoh; H Watanabe; M Yamakido
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

7.  Effect of glutathione depletion on cisplatin resistance in cancer cells transfected with the gamma-glutamylcysteine synthetase gene.

Authors:  H Kurokawa; K Nishio; T Ishida; H Arioka; K Fukuoka; T Nomoto; H Fukumoto; H Yokote; N Saijo
Journal:  Jpn J Cancer Res       Date:  1997-02

8.  Differences in substrate specificity among glutathione conjugates (GS-X) pump family members: comparison between multidrug resistance-associated protein and a novel transporter expressed on a cisplatin-resistant cell line (KCP-4).

Authors:  K Ueda; H Suzuki; S Akiyama; Y Sugiyama
Journal:  Jpn J Cancer Res       Date:  1999-04

9.  Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.

Authors:  S Y Sharp; V Smith; S Hobbs; L R Kelland
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

10.  Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer.

Authors:  Wenjing Wang; Mengyue Zhao; Lijuan Cui; Yong Ren; Jingyuan Zhang; Junli Chen; Lina Jia; Jiayu Zhang; Jingyu Yang; Guoliang Chen; Charles R Ashby; Chunfu Wu; Zhe-Sheng Chen; Lihui Wang
Journal:  Mol Cancer       Date:  2020-09-02       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.